Chang-Yul Kang
Chief Executive Officer at CELLID, CO., LTD.
Net worth: 6 M $ as of 29/04/2024
Network origin in Chang-Yul Kang first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
13
| Public Company | Pharmaceuticals: Other | 13 |
| Public Company | Pharmaceuticals: Major | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Chang-Yul Kang via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AHN-GOOK PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| NEPES CORPORATION | Electronic Components | Director/Board Member | |
| ABLE C&C CO., LTD. | Household/Personal Care | Chief Executive Officer | |
| Yonsei University | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree | |
| Seoul National University | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| Ewha Womans University | College/University | Graduate Degree | |
| Hoechst Marion Roussel, Inc. | Chief Executive Officer | ||
| TOOLGEN INCORPORATED | Medical Specialties | Director/Board Member | |
The Korea Chamber of Commerce & Industry
 The Korea Chamber of Commerce & Industry Miscellaneous Commercial ServicesCommercial Services The Korea Chamber of Commerce & Industry (KCCI) is a business organization that provides resources, publications, events, and networks for its members. The organization is based in Seoul, North Korea and has overseas offices. The KCCI advocates for its members and partners with other organizations to promote bilateral economic cooperation. The KCCI also provides economic data and policy issues publications and hosts business forums and roundtables. Recently, the KCCI hosted a successful business forum with over 600 attendees, including political and business leaders from both countries. The Financial Services Commission identified five bank holding companies and five banks as domestic systemically important banks for 2024, and those identified as D-SIBs are required to set aside an additional common equity capital of 1.0, and the higher loss absorbency requirement will take effect on January 1, 2024. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Chungnam National University | College/University | Undergraduate Degree | |
| GENEXINE, INC. | Biotechnology | Director/Board Member | |
| Ajou University | College/University | Graduate Degree | |
| Korea Pharmaceutical Manufacturers Association | Director/Board Member | ||
| Chung-Ang University | College/University | Undergraduate Degree | |
| REZOLUTE, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Kelley School of Business | College/University | Masters Business Admin | |
| Handok Jeseok Foundation | President | ||
| SOCAR INC. | Packaged Software | Chief Executive Officer | |
| PCL, INC. | Medical Specialties | Director/Board Member | |
pH Pharma Co., Ltd.
 pH Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology pH Pharma Co. Ltd. engages in the developing and manufacturing of bio-pharmaceuticals. Its products include php-303, php-201, ab-101, nuvesse, alpine and torpedo products. The company was founded by Ho Young Huh on September 22, 2015 and is headquartered in Seoul, South Korea. | Pharmaceuticals: Major | Director/Board Member | |
| K CAR CO., LTD. | Specialty Stores | Director/Board Member | |
TRIGR Therapeutics, Inc.
 TRIGR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trigr Therapeutics, Inc. engages in pharmaceuticals industry group. The company is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member | |
| Korea Hoechst Marion Roussel | Chief Executive Officer | ||
| Korean German Society | President | ||
| Korean German Chamber of Commerce & Industry | Director/Board Member | ||
Sanofi-Aventis Korea Co., Ltd.
 Sanofi-Aventis Korea Co., Ltd. Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Korea Co., Ltd. provides pharmaceutical research and development services. Its products include prescription medicine, consumer health care, vaccines, and non-prescription medicine. The company founded in April 1991 and is headquartered in Seoul, South Korea. | Pharmaceuticals: Major | Chief Executive Officer |
Statistics
International
| South Korea | 21 |
| United States | 5 |
| Germany | 3 |
Sectoral
| Health Technology | 9 |
| Consumer Services | 8 |
| Process Industries | 2 |
| Electronic Technology | 2 |
| Consumer Non-Durables | 2 |
Operational
| Director/Board Member | 23 |
| Corporate Officer/Principal | 9 |
| Chief Executive Officer | 8 |
| Undergraduate Degree | 6 |
| Independent Dir/Board Member | 6 |
Most connected contacts
| Insiders | |
|---|---|
| Young-Jin Kim | 15 |
| Jeong-Yeol Jo | 4 |
| Won-Ho Kim | 3 |
| Chan-Hee Han | 3 |
| Chul-Joon Kim | 3 |
| Seong-Joon Hong | 3 |
| Myung-Hwan Park | 3 |
| Young-Geo Seo | 2 |
| Yookyung Kim | 2 |
| BeomSoo Han | 2 |
| Min-Soo Kim | 2 |
| Wie Jong Kwak | 2 |
| Eun-Joo Kim | 1 |
| Eun-Yeong Choi | 1 |
| Young Kim | 1 |
- Stock Market
- Insiders
- Chang-Yul Kang
- Company connections